SOAT1 and temporal arteritis: Among those therapies, inhibitors of JAK-STAT pathway are not only expected to be effective against cellular senescence by suppressing excessive cytokine signaling, but also expected for treating GCA (Zhang et al., 2018; Rathore et al., 2022; Vieira et al., 2022).